Serving ACOs, IDNs & Emerging Provider Networks: Health Outcomes and Future Trends

STUDY OVERVIEW

As a result of the Affordable Care Act on the U.S. healthcare industry, Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs) are playing a bigger role in the payer sector and are accounting for a fast-rising share of total pharma business.

Best Practices, LLC conducted a customized study to better understand the current and expected impact of ACOs/IDNs on pharma companies’ operations. The research also reviews which health outcomes activities can influence ACO/IDN relationships and provides participants' lessons learned regarding the use of ACO/IDN specialists. The study provides Sales and Managed Markets leaders with benchmarks for current and future trends and lessons learned when serving ACOs/IDNs.

This study has small/medium company and large company segments.

KEY TOPICS

• Employing Health Outcomes
• Current and Future Trends
• Lessons Learned

• Top ways to partner with ACOs/IDNs to influence payers
• Types of outcomes research most valued by ACOs/IDNs
• Lessons learned for productively using ACO/IDN specialists

• Treatment protocols will be developed and standardized at the top level in ACO/IDN networks, and cascaded to practitioners within. This practice reduces physicians' treatment options and potentially prevents patient access to effective pharma products.